Radiation enteritis

0
Radiation enteritis

Radiation enteritis is a serious disease that occurs as a result of exposure to ionizing radiation on the mucous membrane of the small and large intestine. This condition is characterized by inflammation of the intestinal wall and disruption of its functionality. Radiation enteritis can manifest itself in a variety of clinical symptoms, including diarrhea, abdominal pain, dyspeptic disorders and a general deterioration in the patient's health. The mechanisms of development of this disease are associated with the damaging effects of radiation on the cellular structures of the intestine, which causes cell death, increased vascular permeability and activation of inflammatory processes. The main dangers of radiation enteritis are its ability to cause serious complications, such as acute intestinal bleeding, stenosis and perforation, which requires adequate and timely intervention.

History of the disease and interesting historical facts

Radiation enteritis was unknown before the advent of medical radiation technology. The first observations of intestinal disorders in patients undergoing radiation therapy date back to the mid-20th century, when radiology was being actively introduced into clinical practice. In 1945, after the atomic bombings of Hiroshima and Nagasaki, the medical community's attention was focused on the effects of radiation exposure, including radiation enteritis. Modern research into this condition continues to elucidate its pathogenesis, clinical manifestations, and treatment approaches. Interesting facts about this disease include the development of new radiation therapy techniques that reduce the risk of radiation enteritis, which is a significant advance in the field of oncology.

Epidemiology

The incidence of radiation enteritis varies depending on the population and the level of radiation therapy. Statistical studies show that 5-15% of patients receiving abdominal radiotherapy may develop radiation enteritis. The incidence of this complication is estimated to range from 25-40% among patients treated for abdominal cancer. The incidence of radiation enteritis increases in patients who receive high doses of radiation, which also depends on the period and nature of previous therapy. It is important to note that this disease may not manifest itself immediately, but months or even years after irradiation, which requires long-term monitoring of the patient's condition.

Genetic predisposition to this disease

To date, the study of genetic predisposition to radiation enteritis continues. Scientific studies have revealed that certain genetic mutations can increase the risk of developing this disease. For example, mutations in genes responsible for DNA repair can play a key role in the sensitivity of intestinal tissue to ionizing radiation. The TP53 and ATM genes have been noted as potential markers of predisposition to radiation enteritis. Patients with polymorphisms of these genes tend to experience higher damage to intestinal tissue under the influence of radiation. Therefore, the importance of genetic testing in such cases becomes relevant, which can help in the development of individualized approaches to the prevention and treatment of radiation enteritis.

Risk factors for the development of this disease

There are several risk factors that contribute to the development of radiation enteritis:

  • Surgical interventions in the abdominal area, especially before radiation.
  • The time and dose of radiation the patient received as part of the treatment.
  • Pre-existing bowel diseases such as Crohn's disease or ulcerative colitis.
  • Specific characteristics of the patient's body, including his age and general health.
  • Cumulative effects of repeated courses of radiation therapy.

Concomitant therapy is also of great importance: taking toxic drugs that can increase damage to intestinal tissue in combination with radio beams. Thus, the complex influence of various factors increases the risk of radiation enteritis.

Diagnosis of this disease

Diagnosis of radiation enteritis involves a multi-step approach based on clinical symptoms and the results of various studies. The main symptoms that patients may experience include:

  • Diarrhea, which can be either acute or chronic.
  • Abdominal pain of varying intensity.
  • Nausea and vomiting.
  • General feeling of malaise.

Laboratory tests may include blood tests for inflammatory markers, as well as stool tests. Radiological examinations such as CT and MRI help visualize changes in the intestinal wall and identify complications. Endoscopy also plays an important role in diagnosis: it allows for a visual assessment of the mucosa and a biopsy for histological examination. Differential diagnosis includes exclusion of infectious diseases, inflammatory bowel diseases, and other causes that cause similar clinical symptoms.

Treatment

Treatment of radiation enteritis involves a comprehensive approach aimed at reducing inflammation and restoring intestinal functionality. The main areas of therapy are:

  • General treatment includes diet therapy, exercise restriction and supportive therapy.
  • Pharmacological treatment may include the administration of anti-inflammatory drugs such as corticosteroids and agents that improve intestinal tissue regeneration.
  • Surgical treatment may be required in case of severe complications such as intestinal obstruction or perforation.
  • Other treatments may include probiotics and biologic therapies to improve the health of the gut microflora.

It is important to note that an individual approach to each patient plays a decisive role in the effectiveness of treatment.

List of medications used to treat this disease

Among the medications used to treat radiation enteritis, the following can be distinguished:

  • Corticosteroids (eg, prednisolone)
  • 5-aminosalicylic acids (eg, mesalazine).
  • Immunosuppressants (eg, azathioprine).
  • Drugs that improve intestinal motility (eg, loperamide).
  • Probiotics to restore normal microflora (eg, Lactobacillus and Bifidobacterium).

The choice of drug therapy depends on the severity of clinical symptoms and the general condition of the patient.

Disease monitoring

Monitoring of the patient's condition with radiation enteritis includes regular follow-up examinations and assessment of clinical symptoms. The prognosis of this disease varies depending on the severity of the condition and the timeliness of treatment. Complications such as intestinal stenosis and perforations can significantly worsen the prognosis and require surgical intervention. Therefore, monitoring of patients receiving radiation therapy should be systematic, and when the first symptoms of radiation enteritis appear, appropriate diagnostic tests should be carried out immediately.

Age-related features of the disease

Radiation enteritis can manifest itself at any age, but its course may vary depending on the age group. In elderly patients, the disease often proceeds more severely due to impaired tissue regenerative capacity and the presence of concomitant diseases. In children and adolescents, as a rule, the development of radiation enteritis may be less pronounced, but a sharper exacerbation of symptoms may occur when critical doses of radiation occur.

Questions and Answers

  • What are the main symptoms of radiation enteritis? The main symptoms include diarrhea, abdominal pain, nausea and a general feeling of malaise.
  • What are the risk factors associated with the development of radiation enteritis? These include previous bowel disease, high doses of radiation and abdominal surgery.
  • How is radiation enteritis diagnosed? Diagnosis includes clinical examinations, laboratory tests, radiological and endoscopic examinations.
  • What is the treatment for radiation enteritis? Treatment includes medication, diet and, in some cases, surgery.
  • What is the prognosis for patients with radiation enteritis? The prognosis varies, but depends on the severity of the disease and the timeliness of treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.